|
Market Closed -
Other stock markets
|
Pre-market 18:21:49 | |||
| 145.21 USD | -0.84% |
|
144.87 | -0.23% |
| 08-10 | Berenberg Adjusts Price Target on Procter & Gamble to $143 From $146, Maintains Hold Rating | MT |
| 08-07 | US wellness shot brand Dose explores sale, sources say | RE |
Company Valuation: Procter & Gamble Company
Data adjusted to current consolidation scope
| Fiscal Period: June | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 344,995 | 357,647 | 389,234 | 373,532 | 341,466 | 337,531 | - | - |
| Change | - | 3.67% | 8.83% | -4.03% | -8.58% | -1.15% | - | - |
| Enterprise Value (EV) 1 | 369,274 | 384,008 | 412,212 | 398,484 | 365,662 | 361,963 | 360,897 | 359,195 |
| Change | - | 3.99% | 7.34% | -3.33% | -8.24% | -1.01% | -0.29% | -0.47% |
| P/E | 24.7x | 25.7x | 27.4x | 24.5x | 22.2x | 21.1x | 19.7x | 18.8x |
| PBR | 7.35x | 7.66x | 8.06x | 7.48x | 6.54x | 6.14x | 5.9x | 5.63x |
| PEG | - | 16.59x | 13.47x | 3.01x | 13.14x | 5.48x | 2.68x | 4x |
| Capitalization / Revenue | 4.3x | 4.36x | 4.63x | 4.43x | 3.92x | 3.8x | 3.69x | 3.57x |
| EV / Revenue | 4.61x | 4.68x | 4.91x | 4.73x | 4.2x | 4.08x | 3.95x | 3.8x |
| EV / EBITDA | 17.9x | 18.4x | 18x | 17.1x | 15.5x | 14.9x | 14.1x | 13.4x |
| EV / EBIT | 20.7x | 21.2x | 20.6x | 19.5x | 17.8x | 17.2x | 16.4x | 15.5x |
| EV / FCF | 27.2x | 27.9x | 24.9x | 27.3x | 24.1x | 23.1x | 21.7x | 20.3x |
| FCF Yield | 3.67% | 3.59% | 4.01% | 3.67% | 4.14% | 4.33% | 4.6% | 4.92% |
| Dividend per Share 2 | 3.523 | 3.681 | 3.829 | 4.076 | 4.259 | 4.412 | 4.608 | 4.826 |
| Rate of return | 2.45% | 2.43% | 2.32% | 2.56% | 2.9% | 3.04% | 3.17% | 3.32% |
| EPS 2 | 5.81 | 5.9 | 6.02 | 6.51 | 6.62 | 6.875 | 7.381 | 7.728 |
| Distribution rate | 60.6% | 62.4% | 63.6% | 62.6% | 64.3% | 64.2% | 62.4% | 62.4% |
| Net sales 1 | 80,187 | 82,006 | 84,039 | 84,284 | 87,032 | 88,745 | 91,481 | 94,561 |
| EBITDA 1 | 20,620 | 20,848 | 22,884 | 23,303 | 23,657 | 24,347 | 25,606 | 26,817 |
| EBIT 1 | 17,813 | 18,134 | 19,988 | 20,456 | 20,497 | 20,990 | 22,055 | 23,116 |
| Net income 1 | 14,742 | 14,653 | 14,879 | 15,974 | 16,046 | 16,539 | 17,558 | 18,265 |
| Net Debt 1 | 24,279 | 26,361 | 22,978 | 24,952 | 24,196 | 24,432 | 23,366 | 21,664 |
| Reference price 2 | 143.79 | 151.74 | 164.92 | 159.32 | 146.64 | 145.21 | 145.21 | 145.21 |
| Nbr of stocks (in thousands) | 2,399,297 | 2,356,969 | 2,360,135 | 2,344,542 | 2,328,599 | 2,324,433 | - | - |
| Announcement Date | 29/7/22 | 28/7/23 | 30/7/24 | 29/7/25 | 29/7/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 21.12x | 4.08x | 14.87x | 3.04% | 338B | |
| 17.76x | 2.71x | 11.95x | 3.55% | 134B | |
| 25.1x | 3.75x | 15.77x | 2.3% | 73.59B | |
| 42.83x | 6.9x | 29.94x | 2.15% | 50.87B | |
| 20.04x | 2.8x | 11.72x | 4.44% | 36.59B | |
| 84.9x | 2.5x | 15.06x | 1.6% | 31.76B | |
| 24.42x | 1.81x | 11.5x | 2.09% | 21.23B | |
| 21.02x | 1.38x | 8.85x | 1.23% | 20.08B | |
| 16.04x | 1.54x | 8.78x | 3.3% | 19.81B | |
| 43.91x | 6.18x | 30.26x | 1.66% | 11B | |
| Average | 31.71x | 3.36x | 15.87x | 2.54% | 73.65B | |
| Weighted average by Cap. | 25.40x | 3.68x | 15.13x | 2.91% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- PG Stock
- Valuation Procter & Gamble Company
Select your edition
All financial news and data tailored to specific country editions
